Regeneron Pharmaceuticals (0R2M.L)
$710.6 0%
to add to portfolio
AI Score
-
Alternative
6 -
Fundamental
7 -
Technical
4
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Regeneron Pharmaceuticals, AI stock picks, stock alerts and much more.
0R2M.L AI Stock Analysis
AI stock analysis for 0R2M.L is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Regeneron Pharmaceuticals (0R2M.L) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
0R2M.L Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Regeneron Pharmaceuticals (0R2M.L), currently trading at $710.6, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About 0R2M.L
-
Regeneron Pharmaceuticals, Inc.
-
Symbol
0R2M.L
-
Market
LSE
-
Industry
Medical - Pharmaceuticals
-
Market Cap
76.8B
Similar Stocks
 |
Waters Corporation 0LTI.L |
$370.9 1.9% |
5 |
 |
Vertex Pharmaceuticals Incorporated 0QZU.L |
$407.6 1.6% |
7 |
 |
Neurocrine Biosciences 0K6R.L |
$136.6 0.7% |
8 |
 |
Emergent BioSolutions Inc. 0IGA.L |
$8.34 0.9% |
3 |
 |
Abeona Therapeutics Inc. 0H7R.L |
$5.71 0.7% |
4 |
News
0R2M.L Alternative Data
News Mentions
Sign up to access
Twitter Followers
Sign up to access
TikTok Followers
Sign up to access
Facebook Engagement
Sign up to access
Instagram Followers
Sign up to access
Youtube Subscribers
Sign up to access
LinkedIn Followers
Sign up to access
Job Postings
Sign up to access
LinkedIn Employees
Sign up to access
Web Traffic
Sign up to access
Business Outlook
Sign up to access
0R2M.L Financials
0R2M.L Key Metrics
-
Total Revenue
$3.7B
-
Net Income
$1.3B
-
Earnings per Share
$12.4
-
Free cash flow
$1.1B
-
EBITDA
$1.2B
-
EBITDA Ratio
0.31701
-
Total Assets
$37.4B
0R2M.L 2-year Revenue & Income
0R2M.L 2-year Free Cash Flow
0R2M.L Technicals
0R2M.L SMA
0R2M.L RSI
FAQ
What's the current price of Regeneron Pharmaceuticals (0R2M.L) Stock?
The price of an Regeneron Pharmaceuticals (0R2M.L) share is $710.6.
What's the market cap of Regeneron Pharmaceuticals?
The current market cap of Regeneron Pharmaceuticals is 76.8B.
Should I buy or sell 0R2M.L?
Regeneron Pharmaceuticals shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, Regeneron Pharmaceuticals is better viewed as a hold or accumulate position while waiting for further developments.
Is Regeneron Pharmaceuticals a good investment?
The current analysis of Regeneron Pharmaceuticals' fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in Regeneron Pharmaceuticals' portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.
Is now a good time to buy Regeneron Pharmaceuticals (0R2M.L) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for Regeneron Pharmaceuticals stock is currently neutral, suggesting a cautious approach might be wise.
What are some stocks similar to Regeneron Pharmaceuticals (0R2M.L) that investors often compare it to?
Regeneron Pharmaceuticals (0R2M.L) is often compared to similar stocks such as Waters Corporation, Vertex Pharmaceuticals Incorporated, Neurocrine Biosciences, Emergent BioSolutions Inc. and Abeona Therapeutics Inc..
What is the forecast for Regeneron Pharmaceuticals' stock price in 2025?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Regeneron Pharmaceuticals' stock price to be around $770.8 in 2025. Starting from the current price of $710.6, this represents a 8.5% change in price, indicating a bullish outlook for the stock.
How to buy Regeneron Pharmaceuticals (0R2M.L) Stock?
Regeneron Pharmaceuticals stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Regeneron Pharmaceuticals shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.